Delivering on commitments, executing ahead of expectations, and raising guidanceInnovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine ...

Medtronic plc today announced financial results for its second quarter (Q2) of fiscal year 2025 (FY25), which ended October 25, 2024. Key Highlights Revenue of $8.4 billion increased 5.3% as reported ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $95.85, along ...

Analysts are estimating that Medtronic will report an earnings per share (EPS) of $1.25. Investors in Medtronic are eagerly ...